361 related articles for article (PubMed ID: 27561827)
1. Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study.
Ahmed FW; Rider R; Glanville M; Narayanan K; Razvi S; Weaver JU
Cardiovasc Diabetol; 2016 Aug; 15(1):116. PubMed ID: 27561827
[TBL] [Abstract][Full Text] [Related]
2. Anti-Angiogenic miR-222, miR-195, and miR-21a Plasma Levels in T1DM Are Improved by Metformin Therapy, Thus Elucidating Its Cardioprotective Effect: The MERIT Study.
Ahmed FW; Bakhashab S; Bastaman IT; Crossland RE; Glanville M; Weaver JU
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347712
[TBL] [Abstract][Full Text] [Related]
3. Linagliptin, when compared to placebo, improves CD34+ve endothelial progenitor cells in type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin: a randomized controlled trial.
Awal HB; Nandula SR; Domingues CC; Dore FJ; Kundu N; Brichacek B; Fakhri M; Elzarki A; Ahmadi N; Safai S; Fosso M; Amdur RL; Sen S
Cardiovasc Diabetol; 2020 Jun; 19(1):72. PubMed ID: 32493344
[TBL] [Abstract][Full Text] [Related]
4. The synergistic effects of saxagliptin and metformin on CD34+ endothelial progenitor cells in early type 2 diabetes patients: a randomized clinical trial.
Dore FJ; Domingues CC; Ahmadi N; Kundu N; Kropotova Y; Houston S; Rouphael C; Mammadova A; Witkin L; Khiyami A; Amdur RL; Sen S
Cardiovasc Diabetol; 2018 May; 17(1):65. PubMed ID: 29724198
[TBL] [Abstract][Full Text] [Related]
5. Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes.
Nandula SR; Kundu N; Awal HB; Brichacek B; Fakhri M; Aimalla N; Elzarki A; Amdur RL; Sen S
Cardiovasc Diabetol; 2021 Feb; 20(1):44. PubMed ID: 33581737
[TBL] [Abstract][Full Text] [Related]
6. Upregulated miR-18a-5p in Colony Forming Unit-Hill's in Subclinical Cardiovascular Disease and Metformin Therapy; MERIT Study.
Phowira J; Ahmed FW; Bakhashab S; Weaver JU
Biomedicines; 2022 Aug; 10(9):. PubMed ID: 36140236
[TBL] [Abstract][Full Text] [Related]
7. The inflammation, vascular repair and injury responses to exercise in fit males with and without Type 1 diabetes: an observational study.
West DJ; Campbell MD; Gonzalez JT; Walker M; Stevenson EJ; Ahmed FW; Wijaya S; Shaw JA; Weaver JU
Cardiovasc Diabetol; 2015 Jun; 14():71. PubMed ID: 26044827
[TBL] [Abstract][Full Text] [Related]
8. Effects of pioglitazone versus metformin on circulating endothelial microparticles and progenitor cells in patients with newly diagnosed type 2 diabetes--a randomized controlled trial.
Esposito K; Maiorino MI; Di Palo C; Gicchino M; Petrizzo M; Bellastella G; Saccomanno F; Giugliano D
Diabetes Obes Metab; 2011 May; 13(5):439-45. PubMed ID: 21255215
[TBL] [Abstract][Full Text] [Related]
9. The endothelial status reflected by circulating endothelial cells, circulating endothelial progenitor cells and soluble thrombomodulin in patients with mild and resistant hypertension.
Budzyń M; Gryszczyńska B; Boruczkowski M; Kaczmarek M; Begier-Krasińska B; Osińska A; Bukowska A; Iskra M; Kasprzak MP
Vascul Pharmacol; 2019 Feb; 113():77-85. PubMed ID: 30590133
[TBL] [Abstract][Full Text] [Related]
10. Reducing glucose variability with continuous subcutaneous insulin infusion increases endothelial progenitor cells in type 1 diabetes: an observational study.
Maiorino MI; Casciano O; Della Volpe E; Bellastella G; Giugliano D; Esposito K
Endocrine; 2016 May; 52(2):244-52. PubMed ID: 26184417
[TBL] [Abstract][Full Text] [Related]
11. Effects of acute exercise on circulating endothelial and progenitor cells in children and adolescents with juvenile idiopathic arthritis and healthy controls: a pilot study.
Obeid J; Nguyen T; Cellucci T; Larché MJ; Timmons BW
Pediatr Rheumatol Online J; 2015 Oct; 13(1):41. PubMed ID: 26458943
[TBL] [Abstract][Full Text] [Related]
12. Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus.
Lunder M; Janić M; Japelj M; Juretič A; Janež A; Šabovič M
Cardiovasc Diabetol; 2018 Dec; 17(1):153. PubMed ID: 30509271
[TBL] [Abstract][Full Text] [Related]
13. Upregulated anti-angiogenic miR-424-5p in type 1 diabetes (model of subclinical cardiovascular disease) correlates with endothelial progenitor cells, CXCR1/2 and other parameters of vascular health.
Tamara A; Coulson DJ; Latief JS; Bakhashab S; Weaver JU
Stem Cell Res Ther; 2021 May; 12(1):249. PubMed ID: 33985567
[TBL] [Abstract][Full Text] [Related]
14. Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS pathway in diabetic mice.
Yu JW; Deng YP; Han X; Ren GF; Cai J; Jiang GJ
Cardiovasc Diabetol; 2016 Jun; 15():88. PubMed ID: 27316923
[TBL] [Abstract][Full Text] [Related]
15. Effects of Metformin Added to Insulin in Adolescents with Type 1 Diabetes: An Exploratory Crossover Randomized Trial.
Yang D; Yan J; Deng H; Yang X; Luo S; Zheng X; Lv J; Liang W; Hong M; Wu Z; Yao B; Weng J; Xu W
J Diabetes Res; 2020; 2020():7419345. PubMed ID: 33457425
[TBL] [Abstract][Full Text] [Related]
16. Exercise on Progenitor Cells in Healthy Subjects and Patients with Type 1 Diabetes.
Waclawovsky G; Umpierre D; Figueira FR; De Lima ES; Alegretti AP; Schneider L; Matte US; Rodrigues TC; Schaan BD
Med Sci Sports Exerc; 2016 Feb; 48(2):190-9. PubMed ID: 26312614
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of methods for assessment of circulating endothelial progenitor cells.
George J; Shmilovich H; Deutsch V; Miller H; Keren G; Roth A
Tissue Eng; 2006 Feb; 12(2):331-5. PubMed ID: 16548691
[TBL] [Abstract][Full Text] [Related]
18. Circulating Endothelial Cells, Circulating Endothelial Progenitor Cells, and Circulating Microparticles in Type 1 Diabetes Mellitus.
Zahran AM; Mohamed IL; El Asheer OM; Tamer DM; Abo-ELela MGM; Abdel-Rahim MH; El-Badawy OHB; Elsayh KI
Clin Appl Thromb Hemost; 2019; 25():1076029618825311. PubMed ID: 30760002
[TBL] [Abstract][Full Text] [Related]
19. Increased pre-surgical numbers of endothelial progenitor cells and circulating endothelial cells in colorectal cancer fail to predict outcome.
Ramcharan KS; Lip GY; Stonelake PS; Blann AD
Int J Colorectal Dis; 2015 Mar; 30(3):315-21. PubMed ID: 25598043
[TBL] [Abstract][Full Text] [Related]
20. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.
Brazg R; Xu L; Dalla Man C; Cobelli C; Thomas K; Stein PP
Diabetes Obes Metab; 2007 Mar; 9(2):186-93. PubMed ID: 17300594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
